FDA recall, , Low risk
AbbVie Pred Mild Ophthalmic Suspension
Pred Mild ophthalmic suspension failed stability specifications.
Summary by Recall Canary from the FDA notice
What happened
AbbVie Inc., of North Chicago, Illinois, recalled Pred Mild, prednisolone acetate ophthalmic suspension, USP, 0.12%, 10 mL, Sterile, Rx only, because it failed stability specifications. The recall began May 18, 2026, and was added to the FDA's Enforcement Report on May 27, 2026. The product, distributed nationwide in the US, was recalled in 2,736 bottles.
What to do
We don't have product-specific instructions for this recall. FDA's general advice for medicine recalls:
- Check the FDA or company notice for instructions specific to this product.
- Ask your pharmacist or doctor whether your lot is affected and what to do.
Is yours affected?
Match the NDC and lot code listed under your product.
An NDC (National Drug Code) is usually printed on the drug's label.
- NDC
- 11980-174-10
- Lot code
- 402805
- 407596
Recall details
- Company began the recall
- Sold in
US Nationwide.
- Company
- AbbVie Inc.North Chicago, Illinois
- Hazard
- Quality testing problem
- Risk
Low risk
Taking it is unlikely to cause health problems.
FDA Class III recall · How risk is rated
- Event ID
- 99008
- Recall number
- D-0551-2026
- Quantity recalled
- 2,736 bottles
Timeline
FDA's Enforcement Report is its public list of recalls; FDA adds a recall when it posts it and publishes the list weekly.
Company began the recall
Added to FDA's Enforcement Report · Classified by FDA
Listed on Recall Canary
In FDA's weekly enforcement report
Summary updated
